KAHF Biotech is Rewriting the Future of Cancer Therapy by Hunting the Untouchable Enemies: The Metastatic and Dormant Tumors

We Will Bring Preventive and Therapeutic Approaches Against Metastatic and Dormant Cancer Cells

Dormant Cancer

Dormant cancer cells are tumor cells that lie inactive in the body—often undetectable and resistant to conventional therapies. Though silent, they can awaken months or even years later to cause relapse and metastasis. At KAHF Biotech, we believe targeting these elusive cells is key to achieving long-term remission and true cancer cures. By focusing on dormant and metastatic cells, we aim to rewrite the future of cancer therapy—one that prevents recurrence before it begins.

Metastatic Tumor

Metastatic tumors arise when cancer cells spread from the original tumor to distant organs, forming new, often aggressive growths. These tumors are responsible for the vast majority of cancer deaths and are notoriously difficult to treat. At KAHF Biotech, we are committed to targeting the root drivers of metastasis to stop cancer where it becomes most dangerous.

Technologies

At KAHF Biotech, Inc., we harness the precision of monoclonal antibodies and the gene-silencing power of Dicer-substrate siRNA (DsiRNA) to selectively attack our discovered targets in dormant and metastatic tumor cells—addressing the root drivers of relapse and therapeutic resistance

KAHF Biotech, Inc.

KAHF Biotech is on its way

Collaboration

We Invite Visionary Investors to Join Us in Advancing This Bold New Frontier in Oncology.

Team Work

OUR MISSION

At KAHF Biotech, Inc., we are driven by a simple, yet profound truth: cancer patients deserve more than the silence of being told, “There’s nothing more we can do.” Our name is rooted in the timeless story of KAHF-a story of resilience, refuge, and unwavering faith in the face of great adversity. Just as the youths sought shelter in a cave and were granted protection and time, we strive to offer a refuge for patients and families navigating the storm of cancer.

We believe that every scientific breakthrough is a form of divine timing-that healing comes through both persistence and trust in a higher plan. Our work is more than just medicine; it is a mission to bring hope, strength, and life-saving innovation to those who need it most.

At KAHF Biotech, Inc., we are on a relentless mission to Chase, Capture, and Eliminate metastatic cancer cells. We chase new frontiers in cancer therapy, targeting metastatic disease with cutting-edge research and innovation. We capture cancer with pinpoint accuracy, ensuring our therapies reach the heart of the disease. And, most importantly, we eliminate it-bringing life-saving solutions to those who have run out of options.

Motto: Chase, Capture, Eliminate

KAHF Biotech is in preliminary stage of development. The mission of company is to open a new avenue for treatment and prevention of cancer metastasis. The company’s focus is on Cancer Metastasis Prevention and Elimination.

Mission Statement

Our mission is to seek and establish the foundation to become the industry leader in metastatic cancer drug development, offering refuge to patients battling metastatic tumor cells. We are committed to providing innovative therapies that not only fight cancer but also provide a sanctuary of hope, healing, and strength for those in their most challenging moments.

Vision

Our vision is to revolutionize metastatic cancer treatment by developing impactful, effective, and affordable therapies that are accessible to cancer patients worldwide. We aim to overcome the current challenges of metastatic disease and ensure that groundbreaking treatments reach those who need them most, no matter where they are.

 

OUR SKILLS
Cancer Therapeutic Development and Discovery
Preclinical Development
IND-enabling Studies
Clinical Trials
MSND

Therapeutic Development for Metastatic and Dormant Cancer Cells

KAHF Biotech, Inc.

0
HOURS OF WORK
0
FINISHED WORKS
0
CLIENTS
0
SOCIAL FOLLOWERS

Email address:

Work 1: muhammad_sadeqinezhad@kahfbiotech.com

Work 2: labmsn9@gmail.com